Search

Objectives: The aim the study was to compare two groups of endometrial cancer patients (below and above 45 years of age) in the aspect of clinicopathological and molecular data., Material and Methods: The study encompassed 456 primary tumour samples retrospectively collected from a cohort of endometrial cancer patients, primarily treated by surgery Molecular analysis covered: copy number variations of 10 genes (TOP2A, ERBB1, ERBB2, ERBB3, ERBB4, MYC, CCND1, ESR1, PIK3CA, RAD21) analyzed by quantitative PCR; mRNA expression of 6 genes (SCGB2A2, RAD27, RUNX1, SNAI1, SNAI2, PROM1) analyzed with the use of reverse transcription quantitative PCR; protein expression analysis of 8 markers (PGR, ESR1; ERBB1, ERBB2, ERBB3, ERBB4, TOP2A, pAKT1) performed with the use of immunohistochemistry., Results: The younger group of patients was characterized by less frequent hypertension (p <0.00007), less frequent myometrial infiltration (p=0.002) and longer overall survival (p=0.003). Apart from RAD21 gene aberrations, which were more frequent in younger patients (p=0.02), the study revealed no statistically significant differences between the groups., Conclusions: The study showed no molecular differences in the profile of younger and older endometrial cancer patients. Data on both the prognostic and predictive significance of RAD21 in endometrial cancer are still insufficient. The clinical profile of younger patients with endometrial carcinoma was slightly better when compared to elderly patients. Younger patients were characterized by longer overall survival.

Objectives: We estimated the occurrence of DNA HPV 16 presence in lymph nodes of 25 patients undergoing abdominal operation for cervical carcinoma., Materials and Methods: The presence of HPV 16 DNA was detected during the preoperative diagnosis procedure by the PCR method., Results: According to the histopathological examination, metastases in the lymph nodes were present in material from two patients. It was confirmed HPV 16 DNA was detected with PCP. We found also 6 patients with HPV 16 DNA in their lymph nodes without histological confirmation., Conclusions: We consider PCR detection of HPV DNA as a simple and useful support of pathology diagnosis.

Objectives: We have estimated the incidence of human papilloma virus (HPV) DNA in cervical smears of patients with cervical carcinoma, treated in 1997-1998 at the II Department of Obstetrics and Gynecology, Medical University of Gdańsk, Poland., Materials and Methods: We have examined 107 patients suffering from cervical cancer. The HPV DNA was detected with the polymerase chain reaction (PCR) method using two primer pairs located in the E6, E7 open reading frames. HPV typing was executed by restriction fragments length polymorphism PCR (RFLP-PCR) method., Results: HPV DNA was detected in 75 (70.1%) patients. A group of patients with Ib (43%) and IIa (19.6%) clinical degrees made the highest percentage within the research group. We found no statistically significant differences between various clinical degrees of cervical cancer in the group of patients both HPV positive and negative., Conclusions: The frequency of HPV especially HPV 16 type infection incidence in cervical carcinoma is lower in Gdansk region than currently published.